BSD Medical Announces Nationwide Reimbursement in the Netherlands for Cancer Treatment Using Hyperthermia

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (www.bsdmedical.com) today announced that comprehensive reimbursement in the Netherlands has been established to provide reimbursement for the use of hyperthermia and radiation therapy to treat both superficial and deep cancerous tumors. BSD Medical is a leading developer and worldwide provider of systems designed to deliver both superficial and deep hyperthermia.
MORE ON THIS TOPIC